Polar Asset Management Partners’s Pfizer PFE Stock Holding History

Polar Asset Management Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-54,500	Closed	-$1.52M	–	793
2024 Q2	$1.52M	Buy	+54,500	New	+$1.5M	0.03%	355
2021 Q4	–	Sell	-65,600	Closed	-$2.82M	–	1454
2021 Q3	$2.82M	Buy	+65,600	New	+$2.91M	0.03%	520
2018 Q1	–	Sell	-2,249,236	Closed	-$77.3M	–	379
2017 Q4	$77.3M	Buy	+2,249,236	New	+$76.7M	1.22%	16
2015 Q4	–	Sell	-26,350	Closed	-$829K	–	264
2015 Q3	$785K	Buy	+26,350	New	+$845K	0.05%	177

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Polar Asset Management Partners's PFE Position: Q3 2024 in Review

Polar Asset Management Partners sold out of Pfizer (PFE) in Q3 2024, closing a stake of 54,500 shares — an estimated $1.52M sold.

Polar Asset Management Partners first reported a position in PFE in Q3 2015 and held it in 4 quarters. The position peaked at $77.3M in Q4 2017. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Polar Asset Management Partners reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Polar Asset Management Partners sold 54,500 Pfizer shares in Q3 2024, an estimated $1.52M.
Polar Asset Management Partners first reported a position in Pfizer in Q3 2015 and held it in 4 quarters.
Polar Asset Management Partners's Pfizer position peaked at $77.3M in Q4 2017.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Polar Asset Management Partners's 13F filing for Q3 2024, filed 14 Nov 2024.